semaglutide
-
anti-obesity medicine, antipsychotics, bipolar disorder, British Journal of Psychiatry Open, Editor Simon Bradstreet, GLP-1 receptor agonists, GLP1, meta-analysis, metabolic health, mortality gap, obesity, physical health, psychosis, schizophrenia, semaglutide, systematic review, tirzepatide, weight gain, weight lossNew heavyweight contender against antipsychotic weight gain? Semaglutide enters the ring
Antipsychotics can be life-changing medications, but they often come with an unwelcome…
-
acute ischemic stroke, Brain, Drugs, dulaglutide, exenatide, GLP-1 receptor agonists, liraglutide, neuroprotection, neuroscience, semaglutide, strokeGLP-1 Stroke Review Finds Prevention Signal, No Acute Neuroprotection Proof
A 2026 review concluded that GLP-1 receptor agonists have plausible stroke biology…
-
daytime sleepiness, Drugs, GLP-1, hypersomnolence, iron deficiency, liraglutide, orexin, Ozempic, real-world cohort, semaglutide, side effects, sleep, tirzepatide, TriNetX, WegovyGLP-1 Drugs Linked to 21% Higher Daytime Sleepiness Risk
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) act on the brain as well…
-
Drugs, GLP-1 receptor agonists, Psychiatry, semaglutide, SGLT2 inhibitors, Suicidal Ideation, suicidality, suicide, suicide attempt, target trial emulation, type 2 diabetes, veteransSemaglutide Did Not Increase Suicidality in 102,361 Veterans
A 2026 target-trial emulation involving 102,361 U.S. veterans with type 2 diabetes…
-
anti-obesity medication, Diet & Nutrition, Drugs, effort moralization, GLP-1, medication stigma, moral judgment, obesity stigma, Ozempic, Psychology, semaglutide, social psychology, Wegovy, weight stigma, Weight-loss drugsGLP-1 Weight-Loss Drugs Triggered Effort-Based Stigma in 4 Studies
A 2026 Scientific Reports paper involving 1,205 participants found that people using…
